TopićESimundićAMTtefanovićM. Polymorphism of apoprotein E (APOE), methylenetetrahydrofolate reductase (MTHFR) and paraoxonase (PON1) genes in patients with cerebrovascular disease. Clin Chem Lab Med2001; 39:346–50.
2.
VoetschBBenkeKSPanhuysenCIDamascenoBPLoscalzoJ. The combined effect of paraoxonase promoter and coding region polymorphisms on the risk of arterial ischemic stroke among young adults. Arch Neurol2004; 61:351–6.
3.
RanadeKKirchgessnerTGIakoubovaOA. Evaluation of the paraoxonases as candidate genes for stroke: Gln192Arg polymorphism in the paraoxonase 1 gene is associated with increased risk of stroke. Stroke2005; 36:2346–50.
4.
VoetschBBenkeKSDamascenoBPSiqueiraLHLoscalzoJ. Paraoxonase 192 Gln–>Arg polymorphism: an independent risk factor for nonfatal arterial ischemic stroke among young adults. Stroke2002; 33:1459–64.
5.
UenoTShimazakiEMatsumotoT. Paraoxonase1 polymorphism Leu-Met55 is associated with cerebral infarction in Japanese population. Med Sci Monit2003; 9:208–12.
6.
AydinMGencerMCetinkayaY. PON1 55/192 polymorphism, oxidative stress, type, prognosis and severity of stroke. IUBMB Life2006; 58:165–72.
7.
PasdarARoss-AdamsHCummingA. Paraoxonase gene polymorphisms and haplotype analysis in a stroke population. BMC Med Genet2006; 7:28–32.
8.
XuHWYuanNZhaoZ. Study of the relationship between gene polymorphisms of paraoxonase 2 and stroke in a Chinese population. Cerebrovasc Dis2008; 25:87–94.
9.
WangXChengSBrophyVH. A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in non-hypertensive patients. Stroke2009; 40:683–95.
10.
ShinBSOhSYKimYSKimKW. The paraoxonase gene polymorphism in stroke patients and lipid profile. Acta Neurol Scand2008; 117:237–43.
11.
SaeedMPerwaiz IqbalMYousufFAPerveenSShafiqM. Interactions and associations of paraoxonase gene cluster polymorphisms with myocardial infarction in a Pakistani population. Clin Genet2007; 71:238–44.
